Boston Scientific Corporation (VIE:BSXC)

Market Cap	115.02B -18.6%
Revenue (ttm)	17.10B +19.9%
Net Income	2.47B +56.3%
EPS	1.65 +55.2%
Shares Out	n/a
PE Ratio	46.60
Forward PE	26.22
Dividend	n/a
Ex-Dividend Date	n/a

Volume	436
Average Volume	604
Open	77.40
Previous Close	77.60
Day's Range	77.20 - 78.40
52-Week Range	74.80 - 104.00
Beta	n/a
RSI	41.59
Earnings Date	Feb 4, 2026

About Boston Scientific

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices ...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1979
• Employees: 53,000
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: BSXC

Financial Performance

In 2025, Boston Scientific's revenue was $20.07 billion, an increase of 19.87% compared to the previous year's $16.75 billion. Earnings were $2.90 billion, an increase of 56.40%.

Financial numbers in USD